AngioDynamics, Inc.
ANGO
$13.59
$0.151.12%
NASDAQ
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 320.17M | 313.73M | 307.31M | 300.72M | 292.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 320.17M | 313.73M | 307.31M | 300.72M | 292.50M |
| Cost of Revenue | 145.28M | 143.39M | 139.59M | 137.88M | 134.79M |
| Gross Profit | 174.89M | 170.34M | 167.72M | 162.84M | 157.71M |
| SG&A Expenses | 157.61M | 152.84M | 150.62M | 149.69M | 145.60M |
| Depreciation & Amortization | 10.68M | 10.55M | 10.48M | 10.40M | 10.32M |
| Other Operating Expenses | 138.00K | -493.00K | -493.00K | -493.00K | -493.00K |
| Total Operating Expenses | 342.64M | 333.68M | 327.48M | 323.47M | 316.07M |
| Operating Income | -22.47M | -19.96M | -20.18M | -22.76M | -23.57M |
| Income Before Tax | -36.30M | -31.38M | -27.71M | -32.21M | -34.03M |
| Income Tax Expenses | 442.00K | 12.00K | -2.00K | -107.00K | -39.00K |
| Earnings from Continuing Operations | -36.74 | -31.39 | -27.71 | -32.10 | -33.99 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -36.74M | -31.39M | -27.71M | -32.10M | -33.99M |
| EBIT | -22.47M | -19.96M | -20.18M | -22.76M | -23.57M |
| EBITDA | 188.00K | -166.00K | 343.00K | -1.12M | -1.17M |
| EPS Basic | -0.89 | -0.76 | -0.67 | -0.78 | -0.83 |
| Normalized Basic EPS | -0.28 | -0.24 | -0.23 | -0.27 | -0.27 |
| EPS Diluted | -0.89 | -0.76 | -0.68 | -0.79 | -0.84 |
| Normalized Diluted EPS | -0.28 | -0.24 | -0.23 | -0.27 | -0.27 |
| Average Basic Shares Outstanding | 166.01M | 165.30M | 164.55M | 163.93M | 163.41M |
| Average Diluted Shares Outstanding | 166.01M | 165.30M | 164.55M | 163.93M | 163.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |